Texture analysis of diffusion weighted imaging for the evaluation of glioma heterogeneity based on different regions of interest.
暂无分享,去创建一个
Jiangfen Wu | Kai Xu | Kai Xu | Jiangfen Wu | Shan Wang | Shan Wang | Meng Meng | Xue Zhang | Chen Wu | Ru Wang | Muhammad Umair Sami | Chen Wu | M. Sami | Ru Wang | Xue Zhang | Meng Meng | Xue Zhang | K. Xu
[1] Seung Hong Choi,et al. Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade. , 2011, Radiology.
[2] Bettina Kulle,et al. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas. , 2011, European journal of radiology.
[3] Toshinori Hirai,et al. Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas , 1999, Journal of magnetic resonance imaging : JMRI.
[4] Johannes Gerdes,et al. The Ki‐67 protein: From the known and the unknown , 2000, Journal of cellular physiology.
[5] A. Bjørnerud,et al. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. , 2008, Radiology.
[6] Bal Sanghera,et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? , 2012, Insights into Imaging.
[7] Contribution of the apparent diffusion coefficient in perilesional edema for the assessment of brain tumors. , 2008, Journal of neuroradiology. Journal de neuroradiologie.
[8] Sang Joon Park,et al. Glioma: Application of Whole-Tumor Texture Analysis of Diffusion-Weighted Imaging for the Evaluation of Tumor Heterogeneity , 2014, PloS one.
[9] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[10] M. Kitajima,et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI , 2002, Neuroradiology.
[11] E Le Rumeur,et al. MRI texture analysis on texture test objects, normal brain and intracranial tumors. , 2003, Magnetic resonance imaging.
[12] Jae-Hun Kim,et al. Imaging-Based Tumor Treatment Response Evaluation: Review of Conventional, New, and Emerging Concepts , 2012, Korean journal of radiology.
[13] Rajikha Raja,et al. Assessment of tissue heterogeneity using diffusion tensor and diffusion kurtosis imaging for grading gliomas , 2016, Neuroradiology.
[14] P. LaViolette,et al. Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity , 2010, Journal of magnetic resonance imaging : JMRI.
[15] Maryellen L. Giger,et al. Computerized Analysis of Mammographic Parenchymal Patterns on a Large Clinical Dataset of Full-Field Digital Mammograms: Robustness Study with Two High-Risk Datasets , 2012, Journal of Digital Imaging.
[16] T. Cloughesy,et al. Quantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiochemotherapy. , 2013, Neuro-oncology.
[17] Pantelis Georgiadis,et al. Enhancing the discrimination accuracy between metastases, gliomas and meningiomas on brain MRI by volumetric textural features and ensemble pattern recognition methods. , 2009, Magnetic resonance imaging.
[18] J K Smith,et al. Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. , 2001, AJNR. American journal of neuroradiology.
[19] Vicky Goh,et al. Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[20] P. Grant,et al. Diffusion MR imaging. Theory and applications. , 1999, Neuroimaging clinics of North America.
[21] Benjamin M Ellingson,et al. Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma. , 2012, Neuro-oncology.
[22] Christos Davatzikos,et al. Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme , 2009, Magnetic resonance in medicine.
[23] James M Provenzale,et al. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. , 2002, Radiology.
[24] Balaji Ganeshan,et al. Diagnostic performance of texture analysis on MRI in grading cerebral gliomas. , 2016, European journal of radiology.
[25] Z. Wu,et al. Usefulness of diffusion/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading? , 2006, The British journal of radiology.
[26] D. Demetrick,et al. The Use of Magnetic Resonance Imaging to Noninvasively Detect Genetic Signatures in Oligodendroglioma , 2008, Clinical Cancer Research.
[27] C. Good,et al. Measurements of heterogeneity in gliomas on computed tomography relationship to tumour grade , 2012, Journal of Neuro-Oncology.
[28] A. Maia,et al. MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. , 2005, AJNR. American journal of neuroradiology.
[29] M. Weller. Novel diagnostic and therapeutic approaches to malignant glioma. , 2011, Swiss medical weekly.
[30] Johan Trygg,et al. ADC texture--an imaging biomarker for high-grade glioma? , 2014, Medical physics.
[31] J. M. Taylor,et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. , 2000, Journal of the National Cancer Institute.
[32] Hon J. Yu,et al. Quantitative analysis of lesion morphology and texture features for diagnostic prediction in breast MRI. , 2008, Academic radiology.
[33] Dawit Assefa,et al. Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: a preliminary investigation in terms of identification and segmentation. , 2010, Medical physics.
[34] R. Henriksson,et al. Incidence trends in high-grade primary brain tumors in males and females. , 2017, Oncology letters.
[35] R. Kiss,et al. The combined determination of proliferative activity and cell density in the prognosis of adult patients with supratentorial high-grade astrocytic tumors. , 1997, American journal of clinical pathology.